According to Fig. 2A, the correlation of clinicopathological stages with PHF5A expression was observed in Adrenocortical carcinoma (ACC), COAD, and THCA with a significance level of p-value less than 0.05. The gene discussed is PHF5A; the disease is adrenal cortex carcinoma.